Green MR - Search Results

1

Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine.

Young JA, Howell SB, Green MR. Young JA, et al. Among authors: green mr. Cancer Chemother Pharmacol. 1984;12(1):43-5. doi: 10.1007/BF00255908. Cancer Chemother Pharmacol. 1984. PMID: 6690073

2

Combination intracavitary chemotherapy for malignant pleural disease.

Markman M, Howell SB, Green MR. Markman M, et al. Among authors: green mr. Cancer Drug Deliv. 1984 Fall;1(4):333-6. doi: 10.1089/cdd.1984.1.333. Cancer Drug Deliv. 1984. PMID: 6544129

3

Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.

Markman M, Howell SB, Lucas WE, Pfeifle CE, Green MR. Markman M, et al. Among authors: green mr. J Clin Oncol. 1984 Dec;2(12):1321-6. doi: 10.1200/JCO.1984.2.12.1321. J Clin Oncol. 1984. PMID: 6542584

4

Alternating combination chemotherapy for stages III and IV ovarian carcinoma.

Young JA, Johnson A, Kroener J, Koziol JA, Saltzstein S, Yon JL, Campbell TN, Lucas W, Green MR. Young JA, et al. Among authors: green mr. J Clin Oncol. 1984 Dec;2(12):1317-20. doi: 10.1200/JCO.1984.2.12.1317. J Clin Oncol. 1984. PMID: 6512580

5

Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.

Young JA, Dillman RO, Seagren SL, Taetle R, Rentschler RE, Lea JW Jr, Lehar TJ, Green MR, Stanton W, Mendelsohn J, Royston I. Young JA, et al. Among authors: green mr. Cancer Treat Rep. 1982 Jun;66(6):1399-401. Cancer Treat Rep. 1982. PMID: 6282459

6

Adenocarcinoma of the fallopian tube: report of a case with an unusual pattern of metastasis and response to combination chemotherapy.

Young JA, Kossman CR, Green MR. Young JA, et al. Among authors: green mr. Gynecol Oncol. 1984 Feb;17(2):238-40. doi: 10.1016/0090-8258(84)90082-9. Gynecol Oncol. 1984. PMID: 6546733

7

Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.

Richards F 2nd, Perry DJ, Goutsou M, Modeas C, Muchmore E, Rege V, Chahinian AP, Hirsh V, Poiesz B, Green MR. Richards F 2nd, et al. Among authors: green mr. Cancer. 1991 Jun 15;67(12):2974-9. doi: 10.1002/1097-0142(19910615)67:12<2974::aid-cncr2820671206>3.0.co;2-x. Cancer. 1991. PMID: 1646066 Clinical Trial.

8

Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B.

Vogelzang NJ, Goutsou M, Corson JM, Suzuki Y, Graziano S, Aisner J, Cooper MR, Coughlin KM, Green MR. Vogelzang NJ, et al. Among authors: green mr. Cancer Chemother Pharmacol. 1990;27(3):239-42. doi: 10.1007/BF00685720. Cancer Chemother Pharmacol. 1990. PMID: 2265461 Clinical Trial.

9

Synergistic interaction between topotecan and microtubule-interfering agents.

Bahadori HR, Green MR, Catapano CV. Bahadori HR, et al. Among authors: green mr. Cancer Chemother Pharmacol. 2001 Sep;48(3):188-96. doi: 10.1007/s002800100327. Cancer Chemother Pharmacol. 2001. PMID: 11592339

10

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.

Kumar P, Herndon J 2nd, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ. Kumar P, et al. Among authors: green mr. Cancer. 1996 Jun 1;77(11):2393-9. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2393::AID-CNCR31>3.0.CO;2-Q. Cancer. 1996. PMID: 8635112 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

900 results

Search Page

Filters